Literature DB >> 17239548

Psychiatric symptomatology among individuals in alcohol detoxification treatment.

Mark E Johnson1, Christiane Brems, Michael E Mills, Dennis G Fisher.   

Abstract

The coexistence of psychiatric symptomatology among individuals receiving longer-term treatment for alcohol use disorders has been well-established; however, less is known about comorbidity among individuals receiving alcohol detoxification. Using the Brief Symptom Inventory [BSI; Derogatis, L. R. (1992). BSI: Administration, scoring, and procedures manual--II. Towson, MD: Clinical Psychometric Research], we compared psychiatric symptomatology among 815 individuals receiving short-term detoxification services with normative data from non-patients, psychiatric patients, and out-of-treatment individuals using street drugs. Findings revealed that individuals in the current sample reported a wide range of psychiatric symptoms with over 80% meeting BSI criteria for diagnosable mental illness. These BSI scores were significantly more severe than those reported by out-of-treatment individuals using street drugs and most closely resembled BSI scores reported for adult psychiatric inpatients. Findings suggest that routine screening for severe mental health symptoms appears warranted in detoxification units. Such screening would greatly increase the chance that coexistence of substance use and other psychiatric disorders would be properly addressed in ongoing treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17239548      PMCID: PMC2232900          DOI: 10.1016/j.addbeh.2006.12.007

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  12 in total

1.  Mental health versus substance abuse treatment programs for dually diagnosed patients.

Authors:  A B Primm; M B Gomez; I Tzolova-Iontchev; W Perry; H T Vu; R M Crum
Journal:  J Subst Abuse Treat       Date:  2000-10

2.  Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery.

Authors:  Barbara E Havassy; Jennifer Alvidrez; Karilyn K Owen
Journal:  Am J Psychiatry       Date:  2004-01       Impact factor: 18.112

Review 3.  Comorbidity in Alaska: evidence and implications for treatment and public policy.

Authors:  Christiane Brems; Mark E Johnson
Journal:  Alaska Med       Date:  2004 Jan-Mar

4.  Needle exchange and injection drug use frequency: a randomized clinical trial.

Authors:  Dennis G Fisher; Andrea M Fenaughty; Henry H Cagle; Rebecca S Wells
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

5.  Comparison of the Brief Psychiatric Rating Scale and the Brief Symptom Inventory.

Authors:  K K Morlan; S Y Tan
Journal:  J Clin Psychol       Date:  1998-11

Review 6.  Co-occurring severe mental illness and substance use disorders: a review of recent research.

Authors:  J RachBeisel; J Scott; L Dixon
Journal:  Psychiatr Serv       Date:  1999-11       Impact factor: 3.084

7.  Depression as measured by the Beck Depression Inventory-II among injecting drug users.

Authors:  Mark E Johnson; David B Neal; Christiane Brems; Dennis G Fisher
Journal:  Assessment       Date:  2006-06

8.  Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment.

Authors:  Katherine E Watkins; Sarah B Hunter; Suzanne L Wenzel; Wenli Tu; Susan M Paddock; Anne Griffin; Patricia Ebener
Journal:  Am J Drug Alcohol Abuse       Date:  2004-11       Impact factor: 3.829

9.  Overlap of clusters of psychiatric symptoms among clients of a comprehensive addiction treatment service.

Authors:  Saulo Castel; Brian Rush; Karen Urbanoski; Tony Toneatto
Journal:  Psychol Addict Behav       Date:  2006-03

10.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08
View more
  5 in total

Review 1.  Suicide and alcohol-related disorders in the U.S. Arctic: boosting research to address a primary determinant of health disparities.

Authors:  James Allen; Marya Levintova; Gerald Mohatt
Journal:  Int J Circumpolar Health       Date:  2011-11-01       Impact factor: 1.228

2.  Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders.

Authors:  André Q C Miguel; Brian D Kiluk; Theresa A Babuscio; Charla Nich; Jair J Mari; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2019-03-20       Impact factor: 4.492

3.  In-home mental health treatment for individuals with HIV.

Authors:  Susan S Reif; Brian W Pence; Sara LeGrand; Elena S Wilson; Marvin Swartz; Terry Ellington; Kathryn Whetten
Journal:  AIDS Patient Care STDS       Date:  2012-10-10       Impact factor: 5.078

4.  Contingency management treatments decrease psychiatric symptoms.

Authors:  Nancy M Petry; Sheila M Alessi; Carla J Rash
Journal:  J Consult Clin Psychol       Date:  2013-04-01

5.  Transitions through stages of alcohol involvement: The potential role of mood disorders.

Authors:  Rosa M Crum; Kerry M Green; Elizabeth A Stuart; Lareina N La Flair; Marc Kealhofer; Andrea S Young; Noa Krawczyk; Kayla N Tormohlen; Carla L Storr; Anika A H Alvanzo; Ramin Mojtabai; Lauren R Pacek; Bernadette A Cullen; Beth A Reboussin
Journal:  Drug Alcohol Depend       Date:  2018-04-10       Impact factor: 4.492

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.